Clinical Trial Update: Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating orlistat as adjuvant treatment for obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Orlistat (orlistat)

Snippet

Sponsor: EMS | Conditions: Obesity | Phase 3 | Status: COMPLETED